RestorixHealth, AMT Unite Under New Corporate Branding
28 Feb 2023
Acquisition
Preview
Source: Business Wire
'Bringing the two companies together under one name reinforces their unified position and reputation as leaders in the wound care industry.'
Preview
Source: Business Wire
METAIRIE, La.--(BUSINESS WIRE)--RestorixHealth, the nation’s leading wound care solutions company, is pleased to announce that American Medical Technologies (AMT) and RestorixHealth have completed an extensive rebrand and will unite under the RestorixHealth name.
Since RestorixHealth and AMT’s merger in 2021, the companies have had the opportunity to incorporate their strengths and expertise to broaden their reach across the care continuum. Together, they manage 260 wound centers across 36 states, serve more than 6,000 post-acute facilities across all 50 states and contract with more than 2,400 payers.
Bringing the two companies together under one name reinforces their unified position and reputation as leaders in the wound care industry dedicated to advancing their mission to restore health and improve the quality of life – and access to care – for patients with wounds.
The brand name, RestorixHealth, is rooted in the company’s commitment to restoring health and best reflected the company’s values and commitment to excellence in wound care. In addition, the RestorixHealth At-Home Wound Healing Services and At-Home Wound Care Supplies service lines will join AMT under the RestorixHealth name.
About RestorixHealth
Committed to excellence in wound care, RestorixHealth is the wound care solutions company providing programs, services, products and education across the care continuum. From developing and operating wound centers in partnership with hospitals, through supporting long-term care facilities with education and supplies, to providing in-home care, RestorixHealth’s solutions increase access to care, reduce hospital admissions, lower or avoid direct care costs and most importantly, improve patient outcomes and quality of life. For more information, visit www.RestorixHealth.com.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.